PYPD - PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023 | Benzinga
PETACH TIKVA, Israel, Oct. 09, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that SHIELD I Phase 3 clinical data for D-PLEX100 will be highlighted in a presentation at the American College of Surgeons Clinical Congress 2023, to be held on October 22-25, 2023, in Boston, MA.
American College of Surgeons Clinical Congress 2023
Presentation Title: |
Impact of Locally Applied Doxycycline-Eluting Drug (D-PLEX) on Incisional Infection Rate ... |